Find clinical trials for Adenocarcinoma in Philadelphia, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Adenocarcinoma trials near Philadelphia, PA, USA:
The research study is being conducted to study whether performing injections of a new treatment, called RP2, directly into stomach and esophagus tumo...
Phase 2
Philadelphia, Pennsylvania, United States
to evaluate the safety and efficacy of first-line chemo-immunotherapy combinations in participants with metastatic pancreatic ductal adenocarcinoma...
Phase 1
Philadelphia, Pennsylvania, United States and 5 other locations
This study will evaluate the safety and effectiveness of the combination of pembrolizumab and odetiglucan in patients with metastatic colorectal canc...
Phase 2
Philadelphia, Pennsylvania, United States
resectable gastric, gastroesophageal junction (GEJ), or esophageal adenocarcinoma who have not received previous treatment for the disease....
Phase 2
Newark, Delaware, United States and 63 other locations
The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...
Phase 3
Philadelphia, Pennsylvania, United States of America and 124 other locations
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
The purpose of this study is to test any good and bad effects of the study drug called PEGPH20. PEGPH20 alone is considered investigational. The Food...
Allentown, Pennsylvania, United States and 9 other locations
The goal of this clinical trial is to determine clinical advantages for LP-300 in combination with carboplatin and pemetrexed in the never smoker pat...
Phase 2
Philadelphia, Pennsylvania, United States of America and 16 other locations
The purpose of this study is to combine standard radiation therapy with drugs that encourages the body's immune system against cancer cells and simul...
Phase 2
Philadelphia, Pennsylvania, United States and 4 other locations
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.
Phase 3
Philadelphia, Pennsylvania, United States and 59 other locations
This is a Phase 1a, open label, single dose, extended study of safety and biokinetics of RAD301 in healthy human volunteers and individuals with PDAC.
Phase 1
Princeton, New Jersey, United States and 1 other location
Clinical trials
Research sites
Resources
Legal